In this video update, celebrating the new year, Rob discusses The AACR Special Conference on DNA Damage Repair in California, GM Cancer Conference Awards, Prostate Cancer Foundation meeting, Nathalie Cook’s NIHR Fellowship and the nomination of The Paterson for GM Chamber of Commerce building of the year. Read More
We speak to Dr Emma Woodward and patient Nick Brown about hereditary cancer predisposition and how the ATLAS study can improve cancer early detection in carriers of Li Fraumeni Syndrome. Read More
Researchers from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and University of Manchester have been instrumental in developing the first guideline for cancer screening in an inflammatory muscle disease called “myositis”, which has an increased cancer risk. Read More
In the final update for 2023, Rob looks reflects on the year of cancer research, and celebrates the launch of the MCRC Annual Report. Read More
The year's major achievements include opening our flagship new research building, milestones in clinical research and international partnerships. Read More
November saw the MCRC host our CRUK RadNet Manchester Scientific and MCRC International Advisory Boards, two MCRC Director’s Lectures, and celebrate the first year of our landmark NIHR funded Kenya-Manchester collaboration. Read More
October has been the month of welcome events and conferences including the European Society for Medical Oncology (ESMO) Congress, the Early Detection Conference, and ASTRO 2023. Read More
Recognising her engagement work with local students from working class backgrounds and approach to sustainability, peer support and teaching inside and outside the laboratory. Read More
Breast Cancer Now is helping Dr Sankari Nagarajan and her team discover why some triple negative breast cancers spread to other parts of the body and whether existing drugs can be repurposed to stop this from happening. Read More
We speak to Dr Emma Woodward about changing the standards of care in early detection of Li Fraumeni Syndrome (LFS) and the ATLAS study. Read More
The study found that 61% of all SPED trials focused on just three cancer types – colorectal, breast, and cervical cancer. Read More
September sees us celebrate the successes of our research community and spotlight RAPID-RT and other precision medicine trials. Read More
Swinton cancer patient joins a clinical trial at The Christie at Oldham Read More
The funding will support work to investigate an ‘RNA therapeutic’ to activate the body's immune system. Read More
